JP Stock MarketDetailed Quotes

6857 Advantest

Watchlist

9198.0
-249.0-2.64%

20min DelayNot Open Dec 30 15:30 JST

7.05TMarket Cap109.29P/E (Static)

Advantest Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Advantest H1 FY2025 Earnings Date

Currency：USDOct 30, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	2.29B	--
		+57.39%
EPS	--	0.65	--
		+177.74%

Analyst Rating

Buy

Dec 17, 2024

Advantest Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 177.683B	--
Jan 29, 2025	2025/Q3	-- / 175.017B	--
Oct 30, 2024	2025/Q2	190.500B / 153.944B	--
Jul 31, 2024	2025/Q1	138.725B / 119.883B	--
Apr 26, 2024	2024/Q4	135.763B / 131.459B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 177.683B--

Jan 29, 20252025/Q3-- / 175.017B--

Oct 30, 20242025/Q2190.500B / 153.944B--

Jul 31, 20242025/Q1138.725B / 119.883B--

Apr 26, 20242024/Q4135.763B / 131.459B--

Unlock Free Earnings Estimates

Open Account

Advantest Earnings Reports

Advantest: Confirmation letter

Nov 13, 2024 12:25

Advantest: Semi-annual report - 83rd fiscal year (2024/04/01 - 2025/03/31)

Nov 13, 2024 12:24

Advantest: Notice Concerning Dividends from Surplus Funds (Interim Dividend)

Oct 30, 2024 14:00

Advantest: 2024 2nd quarter Earnings Conference materials

Oct 30, 2024 14:00

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 17, 2024

Buy

Strong Buy

52.94%
Buy

29.41%
Hold

17.65%
Underperform

0.00%
Sell

0.00%

Price Target

No Data

Investment Theme

Semiconductor

Intraday-1.13%